Clinical Trial Update: Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluated letrozole for the prevention of breast cancer in healthy postmenopausal women at high risk; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Letrozole (letrozole)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Healthy, no Evidence of Disease, Lobular Breast Carcinoma in Situ | Phase 1 | Status: COMPLETED